Free Newsletter
Genzyme plant goes idle for sanitizing
Free newsletter via e-mail
Tools
Genzyme is temporarily halting drug production at its Allston, MA, plant due to viral contamination in a bioreactor. Though the virus is not known to be a threat to humans, production will cease for the facility to be sanitized. Genzyme expects the plant to be operational by the end of July. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: